Market Overview Biomarker-driven patient selection is optimizing Keytruda outcomes through precision oncology approaches. Biomarkers optimize treatment through identifying patients most likely to benefit from therapy. Current Market Landscape PD-L1 expression assessment. Tumor mutational burden testing. Microsatellite instability evaluation. DNA mismatch repair deficiency. Genomic profiling....